Doctors discuss use of MenB vaccine at Princeton University

January 5, 2014
Doctors discuss use of MenB vaccine at princeton university
The planned use of an experimental Neisseria meningitides serogroup B meningitis vaccine at the University of Princeton has raised several contentious issues relating to vaccination, according to an ideas and opinions piece published online Dec. 24 in the Annals of Internal Medicine.

(HealthDay)—The planned use of an experimental Neisseria meningitides serogroup B (MenB) meningitis vaccine at the University of Princeton has raised several contentious issues relating to vaccination, according to an ideas and opinions piece published online Dec. 24 in the Annals of Internal Medicine.

Kristen A. Feemster, M.D., M.P.H., and Paul Offit, M.D., from the University of Pennsylvania School of Medicine in Philadelphia, discuss use of the unlicensed (Bexsero) at the University of Princeton, where eight confirmed cases of MenB have been identified.

The authors note that despite a coordinated response from the University, N.J. Department of Health, and U.S. Centers for Disease Control and Prevention, the outbreak persisted. Although concern has been expressed relating to "emergency use" of an , safety has been established in clinical trials and the vaccine is licensed in the European Union and Australia. Vaccine receipt is voluntary, but will be offered to university students and high-risk university-affiliated individuals. Use of the vaccine in this situation has called into question the decision not to distribute the vaccine in the United States. Vaccine manufacturers are currently prioritizing development of a 5-valent vaccine including MenB, and until such time, broader access to Bexsero is considered unlikely.

"While many have also called for wider access to a MenB vaccine, others view Princeton students as test subjects—we want what we cannot have yet also distrust what is unknown," the authors write.

One author disclosed financial ties to Pfizer and Abbott.

Explore further: Princeton to offer meningitis B vaccine to 6,000

More information: Full Text (subscription or payment may be required)

Related Stories

Princeton to offer meningitis B vaccine to 6,000

November 26, 2013
Princeton University says a meningitis vaccine not yet licensed for use in the U.S. will be made available on campus starting Dec. 9 to nearly 6,000 students.

Princeton vaccine reaches 90 percent of eligible

December 13, 2013
Princeton University officials say more than 90 percent of the eligible students and staff received a meningitis vaccine this week as part of the university's effort to halt an outbreak.

Princeton starts mass meningitis B vaccinations (Update 2)

December 9, 2013
Princeton University has begun vaccinating nearly 6,000 students to try to stop an outbreak of type B meningitis in an unusual federal government-endorsed administration of a drug not generally approved for use in the United ...

Princeton U. to give students meningitis B vaccine (Update 2)

November 18, 2013
Princeton University officials decided Monday to make available a meningitis vaccine that hasn't been approved in the U.S. to stop the spread of the sometimes deadly disease on campus.

Bridging the gap: Hope that all Meningitis strains will be vaccinated for

February 27, 2013
Scientists at the University of Southampton have taken a significant and important step in keeping people safe from the most common form of meningitis in the UK.

Princeton students safe to travel despite meningitis outbreak: CDC

November 26, 2013
(HealthDay)—Despite recent outbreaks of bacterial meningitis at Princeton University and the University of California, Santa Barbara, U.S. heath officials said Monday that students are safe to travel home for the Thanksgiving ...

Recommended for you

Study suggests ending opioid epidemic will take years

July 20, 2017
The question of how to stem the nation's opioid epidemic now has a major detailed response. A new study chaired by University of Virginia School of Law Professor Richard Bonnie provides extensive recommendations for curbing ...

Team-based model reduces prescription opioid use among patients with chronic pain by 40 percent

July 17, 2017
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which ...

Private clinics' peddling of unproven stem cell treatments is unsafe and unethical

July 7, 2017
Stem cell science is an area of medical research that continues to offer great promise. But as this week's paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, ...

Popular heartburn drugs linked to higher death risk

July 4, 2017
Popular heartburn drugs called proton pump inhibitors (PPIs) have been linked to a variety of health problems, including serious kidney damage, bone fractures and dementia. Now, a new study from Washington University School ...

Most reproductive-age women using opioids also use another substance

June 30, 2017
The majority of reproductive-age and pregnant women who use opioids for non-medical purposes also use at least one other substance, ranging from nicotine or alcohol to cocaine, according to a University of Pittsburgh Graduate ...

At-risk chronic pain patients taper opioids successfully with psychological tools

June 28, 2017
Psychological support and new coping skills are helping patients at high risk of developing chronic pain and long-term, high-dose opioid use taper their opioids and rebuild their lives with activities that are meaningful ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.